ArticleJournal of pharmaceutical policy and practice2026
Implementing the national action plans on antimicrobial resistance in Jordan: document analysis and policymakers' perspectives.
Article in Journal of pharmaceutical policy and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The World Health Organization (WHO) developed the Global Action Plan (GAP) on Antimicrobial Resistance (AMR) in response to its growing threat to human, animal, and agricultural health. Countries worldwide were encouraged to implement National Action Plans (NAPs) to combat AMR. However, low- and middle-income countries (LMICs) face difficulties in implementing NAPs. This study aimed to investigate the implementation of AMR policy in Jordan and assess progress under its NAP. Methods: Using the Implementation Research (IR) framework, this study involved documentary analysis of five policy documents and 17 semi-structured interviews with policymakers. Guided by the IR framework's three phases (proof of concept, proof of implementation, informing scale-up), document analysis was conducted deductively, while the interviews were analysed inductively and deductively using thematic analysis supported by NVivo. Results: Three key themes emerged: implementation challenges, strategy design, and outcome evaluation. Problem identification and context analysis showed that while Jordan's NAP aligns with the WHO's GAP, poor intersectoral coordination, limited stakeholder engagement, and weak enforcement hinder implementation. Participants noted unclear roles for policymakers, creating accountability gaps and inefficiencies. Implementation strategies showed that AMR interventions focus on hospitals, with little attention to other sectors (community pharmacy and primary care). Differences between public and private hospitals led to inconsistent enforcement, while unenforced community pharmacy regulation allowed for unregulated access to antibiotics. Monitoring and evaluating AMR interventions remain key gaps, with a lack of standardised frameworks, fragmented surveillance data, and insufficient monitoring capacity. Conclusion: Although aligned with WHO's GAP, AMR policy implementation in Jordan is hindered by systemic barriers: weak enforcement, limited stakeholder engagement, and fragmented accountability. A focus on hospitals left other settings with limited action or reinforcement. The findings highlighted the need for cross-sector coordination and robust monitoring. While context-specific, these insights may inform AMR governance in comparable settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.